LB-102 has potential to be the first benzamide approved for schizophrenia in the U.S.NOVA-2 trial to enroll approximately 460 patientsPrimary ...
A massive study of 700,000 medical records reveals that teenagers with cannabis use disorder face a 52% higher risk of ...
I remember the first time I heard the time "treatment resistant." It was from a friend as they shared with me their mental health story. As this conversation took place some years before my schooling ...
New research suggests that immune system activity may play a role in the development of several major mental health conditions. The study, published inMolecular Psychiatry, identified 29 ...
Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms ...
Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms ...
Researchers say discovery could establish the basis for a novel, tandem biomarker-peptide therapeutic approach to ...
Helping patients navigate disability outside the clinic is critical to rehabilitation for physical conditions. People with ...